 |
Lung cancer fact sheet in Korea 2026 발간 안내
|
|
2026.10.27 |
24 |
 |
대한폐암학회 코호트 정의서 안내
|
|
2025.06.04 |
1,338 |
 |
폐암진료지침 3판
|
|
2023.12.06 |
17,690 |
 |
NCCN 가이드라인
|
|
2023.08.09 |
10,235 |
 |
국가폐암검진 질지침, 포켓북 안내
|
|
2023.08.08 |
3,569 |
| 10 |
SCLC NCCN Guideline V.2.2009
|
|
2009.03.15 |
1,579 |
| 9 |
NSCLC NCCN Guideline V.2.2009
|
|
2009.03.15 |
1,121 |
| 8 |
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 2009;45(2):228-247.
|
|
2009.03.15 |
2,656 |
| 7 |
Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline, Journal of Clinical Oncology, 2007;25(34):5506-5518
|
|
2008.01.03 |
781 |
| 6 |
Cancer Care Ontario and ASCO adjuvant chemotherapy and adjuvant RT for stage I-IIIA resectable NSCLC guideline
|
|
2007.11.07 |
734 |
| 5 |
Diagnosis and management of lung cancer: ACCP guidelines (2nd edition) Chest, Volume 132/Number 3 Supplement/September, 2007
|
|
2007.11.06 |
1,095 |
| 4 |
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline. Journal of Clinical Oncology 2004;22:330-353.
|
|
2007.11.06 |
847 |
| 3 |
SCLC, NCCN guideline v.1.2008
|
|
2007.11.06 |
744 |
| 2 |
NSCLC, NCCN guideline v.2.2008
|
|
2007.11.06 |
840 |